Search

Your search keyword '"Gassan, Massarweh"' showing total 115 results

Search Constraints

Start Over You searched for: Author "Gassan, Massarweh" Remove constraint Author: "Gassan, Massarweh"
115 results on '"Gassan, Massarweh"'

Search Results

1. Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240

2. Identification of late-stage tau accumulation using plasma phospho-tau217Research in context

Catalog

Books, media, physical & digital resources

3. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology

4. 14-3-3 $$\upzeta /\updelta$$ ζ / δ -reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2

5. Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET

6. [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

7. Reduced Metabotropic Glutamate Receptor Type 5 Availability in the Epileptogenic Hippocampus: An in vitro Study

8. Preliminary Evaluations of [11C]Verubulin: Implications for Microtubule Imaging With PET

9. Author Correction: [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease

11. Large-scale mGluR5 network abnormalities linked to epilepsy duration in focal cortical dysplasia

12. In vivo quantification of neurofibrillary tangles with [18F]MK-6240

13. Integrating machine learning and digital microfluidics for screening experimental conditions

14. Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain

15. The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions

16. Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment

17. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging

20. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F]THK5351 uptake in progressive supranuclear palsy

21. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer’s disease

22. Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset

23. Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s disease

24. Tau phosphorylation is more closely associated with amyloid‐β plaques than with tau neurofibrillary tangles

25. Situating tau pathology and neuroinflammation along the principal gradients of brain organisation in Alzheimer’s disease

26. Verbal recognition declines in later Braak Stages compared to verbal delayed recall

27. Biomarker modelling of Alzheimer's disease using in vivo Braak staging

28. Discordance and Concordance Between Cerebrospinal and [18F]FDG-PET Biomarkers in Assessing Atypical and Early-Onset AD Dementia Cases

29. Microglial activation and tau propagate jointly across Braak stages

30. Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer’s disease therapeutic

31. Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer's disease

33. Topographic Distribution of Amyloid-β, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease

34. First-in-human imaging and kinetic analysis of vesicular acetylcholine transporter density in the heart using [18F]FEOBV PET

35. Determining Amyloid-β Positivity Using 18F-AZD4694 PET Imaging

36. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles

37. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease

38. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

39. APOEε4 potentiates the relationship between amyloid-β and tau pathologies

40. Radiosynthesis and

42. Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors

43. Microglial activation and tau propagate jointly across Braak stages

44. Discordance and Concordance Between Cerebrospinal and [

45. Longitudinal (18)F-MK-6240 tau tangles accumulation follows Braak stages

46. Preliminary Evaluations of [11C]Verubulin: Implications for Microtubule Imaging With PET

47. Preclinical

48. In vivo hippocampal cornu ammonis 1-3 glutamatergic abnormalities are associated with temporal lobe epilepsy surgery outcomes

49. Publisher Correction: Microglial activation and tau propagate jointly across Braak stages

50. Frequency of biologically-defined AD in relation to age, sex, APOEε4 and cognitive impairment